HK2: a Potential Regulator of Osteoarthritis Via Glycolytic and Non-glycolytic Pathways

Overview

Journal Cell Commun Signal

Publisher Biomed Central

Specialties Biochemistry
Cell Biology

Date 2022 Aug 30

PMID 36042519

Authors

Chuncha Bao

Siyi Zhu

Kangping Song

Chengqi He

Affiliations

Soon will be listed here.

Abstract

Osteoarthritis (OA) is an age-related chronic degenerative joint disease where the main characteristics include progressive degeneration of cartilage, varying degrees of synovitis, and periarticular osteogenesis. However, the underlying factors involved in OA pathogenesis remain elusive which has resulted in poor clinical treatment effect. Recently, glucose metabolism changes provide a new perspective on the pathogenesis of OA. Under the stimulation of external environment, the metabolic pathway of chondrocytes tends to change from oxidative phosphorylation (OXPHOS) to aerobic glycolysis. Previous studies have demonstrated that glycolysis of synovial tissue is increased in OA. The hexokinase (HK) is the first rate limiting enzyme in aerobic glycolysis, participating and catalyzing the main pathway of glucose utilization. An isoform of HKs, HK2 is considered to be a key regulator of glucose metabolism, promotes the transformation of glycolysis from OXPHOS to aerobic glycolysis. Moreover, the expression level of HK2 in OA synovial tissue (FLS) was higher than that in control group, which indicated the potential therapeutic effect of HK2 in OA. However, there is no summary to help us understand the potential therapeutic role of glucose metabolism in OA. Therefore, this review focuses on the properties of HK2 and existing research concerning HK2 and OA. We also highlight the potential role and mechanism of HK2 in OA. Video abstract.

Citing Articles

The role of metabolites in the progression of osteoarthritis: Mechanisms and advances in therapy.

Liu X, Zheng Y, Li H, Ma Y, Cao R, Zheng Z J Orthop Translat. 2025; 50:56-70.

PMID: 39868350 PMC: 11762942. DOI: 10.1016/j.jot.2024.10.003.

Novel insights into the role of metabolic disorder in osteoarthritis.

Yu C, Zhao S, Yue S, Chen X, Dong Y Front Endocrinol (Lausanne). 2025; 15():1488481.

PMID: 39744183 PMC: 11688211. DOI: 10.3389/fendo.2024.1488481.

USP22 Promotes Osteosarcoma Progression by Stabilising β-Catenin and Upregulating HK2 and Glycolysis.

Chen S, Hu X, Yi X, Deng X, Xiong T, Ou Y J Cell Mol Med. 2024; 28(23):e70239.

PMID: 39661501 PMC: 11633763. DOI: 10.1111/jcmm.70239.

Targeting Glycolytic Reprogramming in Cholangiocarcinoma: A Novel Approach for Metabolic Therapy.

Hao L, Li S, Peng Q, Zhang J, Deng J, Hu X J Inflamm Res. 2024; 17:9665-9681.

PMID: 39618935 PMC: 11606715. DOI: 10.2147/JIR.S497551.

TLR2 reprograms glucose metabolism in CD4 T cells of rheumatoid arthritis patients to mediate cell hyperactivation and TNF-α secretion.

Lin Q, Zhang C, Huang H, Bai Z, Liu J, Zhang Y Clin Rheumatol. 2024; 43(11):3537-3549.

PMID: 39356380 DOI: 10.1007/s10067-024-07125-w.

References

Sun K, Luo J, Guo J, Yao X, Jing X, Guo F . The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative review. Osteoarthritis Cartilage. 2020; 28(4):400-409. DOI: 10.1016/j.joca.2020.02.027. View

Zhang X, Wang R, Hu D, Sun X, Fujioka H, Lundberg K . Oligodendroglial glycolytic stress triggers inflammasome activation and neuropathology in Alzheimer's disease. Sci Adv. 2020; 6(49). PMC: 7717916. DOI: 10.1126/sciadv.abb8680. View

Gao N, Ding L, Pang J, Zheng Y, Cao Y, Zhan H . Metabonomic-Transcriptome Integration Analysis on Osteoarthritis and Rheumatoid Arthritis. Int J Genomics. 2020; 2020:5925126. PMC: 6961787. DOI: 10.1155/2020/5925126. View

Jeong J, Jang H, Kwak S, Sung G, Park S, Song J . Novel TGF-β1 inhibitor antagonizes TGF-β1-induced epithelial-mesenchymal transition in human A549 lung cancer cells. J Cell Biochem. 2018; 120(1):977-987. DOI: 10.1002/jcb.27460. View

Gall J, Wong V, Pimental D, Havasi A, Wang Z, Pastorino J . Hexokinase regulates Bax-mediated mitochondrial membrane injury following ischemic stress. Kidney Int. 2011; 79(11):1207-16. PMC: 3361076. DOI: 10.1038/ki.2010.532. View

Harrell C, Markovic B, Fellabaum C, Arsenijevic A, Volarevic V . Mesenchymal stem cell-based therapy of osteoarthritis: Current knowledge and future perspectives. Biomed Pharmacother. 2018; 109:2318-2326. DOI: 10.1016/j.biopha.2018.11.099. View

Zhou L, Wang Y, Zhou M, Zhang Y, Wang P, Li X . HOXA9 inhibits HIF-1α-mediated glycolysis through interacting with CRIP2 to repress cutaneous squamous cell carcinoma development. Nat Commun. 2018; 9(1):1480. PMC: 5902613. DOI: 10.1038/s41467-018-03914-5. View

Hampton H, Hutcheon C, Subramanian N . NAGging Hexokinase PEPs up NLRP3. Cell Host Microbe. 2016; 20(2):130-2. DOI: 10.1016/j.chom.2016.07.017. View

Wang Y, Zhao X, Lotz M, Terkeltaub R, Liu-Bryan R . Mitochondrial biogenesis is impaired in osteoarthritis chondrocytes but reversible via peroxisome proliferator-activated receptor γ coactivator 1α. Arthritis Rheumatol. 2015; 67(8):2141-53. PMC: 4519411. DOI: 10.1002/art.39182. View

10.

Ohashi Y, Takahashi N, Terabe K, Tsuchiya S, Kojima T, Knudson C . Metabolic reprogramming in chondrocytes to promote mitochondrial respiration reduces downstream features of osteoarthritis. Sci Rep. 2021; 11(1):15131. PMC: 8302637. DOI: 10.1038/s41598-021-94611-9. View

11.

Bhalla K, Jaber S, Nahid M N, Underwood K, Beheshti A, Landon A . Role of hypoxia in Diffuse Large B-cell Lymphoma: Metabolic repression and selective translation of HK2 facilitates development of DLBCL. Sci Rep. 2018; 8(1):744. PMC: 5768748. DOI: 10.1038/s41598-018-19182-8. View

12.

June R, Liu-Bryan R, Long F, Griffin T . Emerging role of metabolic signaling in synovial joint remodeling and osteoarthritis. J Orthop Res. 2016; 34(12):2048-2058. PMC: 5365077. DOI: 10.1002/jor.23420. View

13.

Alatshan A, Kovacs G, Aladdin A, Czimmerer Z, Tar K, Benko S . All-Trans Retinoic Acid Enhances both the Signaling for Priming and the Glycolysis for Activation of NLRP3 Inflammasome in Human Macrophage. Cells. 2020; 9(7). PMC: 7407903. DOI: 10.3390/cells9071591. View

14.

DeWaal D, Nogueira V, Terry A, Patra K, Jeon S, Guzman G . Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin. Nat Commun. 2018; 9(1):446. PMC: 5792493. DOI: 10.1038/s41467-017-02733-4. View

15.

Pastorino J, Shulga N, Hoek J . Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J Biol Chem. 2001; 277(9):7610-8. DOI: 10.1074/jbc.M109950200. View

16.

Wang C, Silverman R, Shen J, OKeefe R . Distinct metabolic programs induced by TGF-β1 and BMP2 in human articular chondrocytes with osteoarthritis. J Orthop Translat. 2018; 12:66-73. PMC: 5866480. DOI: 10.1016/j.jot.2017.12.004. View

17.

Wang Y, Xian H, Qi J, Wei F, Cheng X, Li S . Inhibition of glycolysis ameliorate arthritis in adjuvant arthritis rats by inhibiting synoviocyte activation through AMPK/NF-кB pathway. Inflamm Res. 2020; 69(6):569-578. DOI: 10.1007/s00011-020-01332-2. View

18.

Lee H, Li C, Ruan D, He J, Montal E, Lorenz S . Non-proteolytic ubiquitination of Hexokinase 2 by HectH9 controls tumor metabolism and cancer stem cell expansion. Nat Commun. 2019; 10(1):2625. PMC: 6573064. DOI: 10.1038/s41467-019-10374-y. View

19.

Li H, Guo H, Xu C, Liu L, Hu S, Hu Z . Inhibition of glycolysis by targeting lactate dehydrogenase A facilitates hyaluronan synthase 2 synthesis in synovial fibroblasts of temporomandibular joint osteoarthritis. Bone. 2020; 141:115584. DOI: 10.1016/j.bone.2020.115584. View

20.

Windhaber R, Wilkins R, Meredith D . Functional characterisation of glucose transport in bovine articular chondrocytes. Pflugers Arch. 2003; 446(5):572-7. DOI: 10.1007/s00424-003-1080-5. View